Ye S - Search Results

1

Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.

Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, Watkins H, Henney AM. Zhang B, et al. Among authors: ye s. Circulation. 1999 Apr 13;99(14):1788-94. doi: 10.1161/01.cir.99.14.1788. Circulation. 1999. PMID: 10199873

2

Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression.

Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM. Ye S, et al. J Biol Chem. 1996 May 31;271(22):13055-60. doi: 10.1074/jbc.271.22.13055. J Biol Chem. 1996. PMID: 8662692 Free article.

3

Human stromelysin gene promoter activity is modulated by transcription factor ZBP-89.

Ye S, Whatling C, Watkins H, Henney A. Ye S, et al. FEBS Lett. 1999 May 7;450(3):268-72. doi: 10.1016/s0014-5793(99)00509-8. FEBS Lett. 1999. PMID: 10359087 Free article.

4

Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1.

Zhang B, Henney A, Eriksson P, Hamsten A, Watkins H, Ye S. Zhang B, et al. Among authors: ye s. Hum Genet. 1999 Nov;105(5):418-23. doi: 10.1007/s004390051124. Hum Genet. 1999. PMID: 10598806

5

Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease.

Jormsjö S, Ye S, Moritz J, Walter DH, Dimmeler S, Zeiher AM, Henney A, Hamsten A, Eriksson P. Jormsjö S, et al. Among authors: ye s. Circ Res. 2000 May 12;86(9):998-1003. doi: 10.1161/01.res.86.9.998. Circ Res. 2000. PMID: 10807873

6

Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis.

Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM. Ye S, et al. Br Heart J. 1995 Mar;73(3):209-15. doi: 10.1136/hrt.73.3.209. Br Heart J. 1995. PMID: 7727178 Free PMC article. Clinical Trial.

7

The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde.

Ye S, Green FR, Scarabin PY, Nicaud V, Bara L, Dawson SJ, Humphries SE, Evans A, Luc G, Cambou JP, et al. Ye S, et al. Thromb Haemost. 1995 Sep;74(3):837-41. Thromb Haemost. 1995. PMID: 8571307

8

Matrix metalloproteinases: implication in vascular matrix remodelling during atherogenesis.

Ye S, Humphries S, Henney A. Ye S, et al. Clin Sci (Lond). 1998 Feb;94(2):103-10. doi: 10.1042/cs0940103. Clin Sci (Lond). 1998. PMID: 9536917 Review.

9

Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis.

de Maat MP, Jukema JW, Ye S, Zwinderman AH, Moghaddam PH, Beekman M, Kastelein JJ, van Boven AJ, Bruschke AV, Humphries SE, Kluft C, Henney AM. de Maat MP, et al. Among authors: ye s. Am J Cardiol. 1999 Mar 15;83(6):852-6. doi: 10.1016/s0002-9149(98)01073-x. Am J Cardiol. 1999. PMID: 10190398

10

Detecting polymorphisms in MMP genes.

Ye S, Henney AM. Ye S, et al. Methods Mol Biol. 2001;151:367-75. doi: 10.1385/1-59259-046-2:367. Methods Mol Biol. 2001. PMID: 11217312 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,159 results

Search Page